BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29193904)

  • 1. Somatic mosaicism of an intragenic FANCB duplication in both fibroblast and peripheral blood cells observed in a Fanconi anemia patient leads to milder phenotype.
    Asur RS; Kimble DC; Lach FP; Jung M; Donovan FX; Kamat A; Noonan RJ; Thomas JW; Park M; Chines P; Vlachos A; Auerbach AD; Smogorzewska A; Chandrasekharappa SC
    Mol Genet Genomic Med; 2018 Jan; 6(1):77-91. PubMed ID: 29193904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of clinical severity with FANCB variant type in Fanconi anemia.
    Jung M; Ramanagoudr-Bhojappa R; van Twest S; Rosti RO; Murphy V; Tan W; Donovan FX; Lach FP; Kimble DC; Jiang CS; Vaughan R; Mehta PA; Pierri F; Dufour C; Auerbach AD; Deans AJ; Smogorzewska A; Chandrasekharappa SC
    Blood; 2020 Apr; 135(18):1588-1602. PubMed ID: 32106311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fanconi anaemia complementation group B presenting as X linked VACTERL with hydrocephalus syndrome.
    Holden ST; Cox JJ; Kesterton I; Thomas NS; Carr C; Woods CG
    J Med Genet; 2006 Sep; 43(9):750-4. PubMed ID: 16679491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia.
    Virts EL; Jankowska A; Mackay C; Glaas MF; Wiek C; Kelich SL; Lottmann N; Kennedy FM; Marchal C; Lehnert E; Scharf RE; Dufour C; Lanciotti M; Farruggia P; Santoro A; Savasan S; Scheckenbach K; Schipper J; Wagenmann M; Lewis T; Leffak M; Farlow JL; Foroud TM; Honisch E; Niederacher D; Chakraborty SC; Vance GH; Pruss D; Timms KM; Lanchbury JS; Alpi AF; Hanenberg H
    Hum Mol Genet; 2015 Sep; 24(18):5093-108. PubMed ID: 26085575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia.
    Chandrasekharappa SC; Lach FP; Kimble DC; Kamat A; Teer JK; Donovan FX; Flynn E; Sen SK; Thongthip S; Sanborn E; Smogorzewska A; Auerbach AD; Ostrander EA;
    Blood; 2013 May; 121(22):e138-48. PubMed ID: 23613520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of pathogenic deletion variants in Fanconi anemia genes.
    Flynn EK; Kamat A; Lach FP; Donovan FX; Kimble DC; Narisu N; Sanborn E; Boulad F; Davies SM; Gillio AP; Harris RE; MacMillan ML; Wagner JE; Smogorzewska A; Auerbach AD; Ostrander EA; Chandrasekharappa SC
    Hum Mutat; 2014 Nov; 35(11):1342-53. PubMed ID: 25168418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenotype of FancB-mutant mouse embryonic stem cells.
    Kim TM; Ko JH; Choi YJ; Hu L; Hasty P
    Mutat Res; 2011 Jul; 712(1-2):20-7. PubMed ID: 21458466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked VACTERL with hydrocephalus syndrome: further delineation of the phenotype caused by FANCB mutations.
    McCauley J; Masand N; McGowan R; Rajagopalan S; Hunter A; Michaud JL; Gibson K; Robertson J; Vaz F; Abbs S; Holden ST
    Am J Med Genet A; 2011 Oct; 155A(10):2370-80. PubMed ID: 21910217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype associations in Fanconi anemia: A literature review.
    Fiesco-Roa MO; Giri N; McReynolds LJ; Best AF; Alter BP
    Blood Rev; 2019 Sep; 37():100589. PubMed ID: 31351673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive molecular study identified 12 complementation groups with 56 novel FANC gene variants in Indian Fanconi anemia subjects.
    George M; Solanki A; Chavan N; Rajendran A; Raj R; Mohan S; Nemani S; Kanvinde S; Munirathnam D; Rao S; Radhakrishnan N; Lashkari HP; Ghildhiyal RG; Manglani M; Shanmukhaiah C; Bhat S; Ramesh S; Cherian A; Junagade P; Vundinti BR
    Hum Mutat; 2021 Dec; 42(12):1648-1665. PubMed ID: 34585473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology.
    De Rocco D; Bottega R; Cappelli E; Cavani S; Criscuolo M; Nicchia E; Corsolini F; Greco C; Borriello A; Svahn J; Pillon M; Mecucci C; Casazza G; Verzegnassi F; Cugno C; Locasciulli A; Farruggia P; Longoni D; Ramenghi U; Barberi W; Tucci F; Perrotta S; Grammatico P; Hanenberg H; Della Ragione F; Dufour C; Savoia A;
    Haematologica; 2014 Jun; 99(6):1022-31. PubMed ID: 24584348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein.
    Fei P; Yin J; Wang W
    Cell Cycle; 2005 Jan; 4(1):80-6. PubMed ID: 15611632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for subcomplexes in the Fanconi anemia pathway.
    Medhurst AL; Laghmani el H; Steltenpool J; Ferrer M; Fontaine C; de Groot J; Rooimans MA; Scheper RJ; Meetei AR; Wang W; Joenje H; de Winter JP
    Blood; 2006 Sep; 108(6):2072-80. PubMed ID: 16720839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism.
    Waisfisz Q; Morgan NV; Savino M; de Winter JP; van Berkel CG; Hoatlin ME; Ianzano L; Gibson RA; Arwert F; Savoia A; Mathew CG; Pronk JC; Joenje H
    Nat Genet; 1999 Aug; 22(4):379-83. PubMed ID: 10431244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.
    Kalb R; Neveling K; Hoehn H; Schneider H; Linka Y; Batish SD; Hunt C; Berwick M; Callen E; Surralles J; Casado JA; Bueren J; Dasi A; Soulier J; Gluckman E; Zwaan CM; van Spaendonk R; Pals G; de Winter JP; Joenje H; Grompe M; Auerbach AD; Hanenberg H; Schindler D
    Am J Hum Genet; 2007 May; 80(5):895-910. PubMed ID: 17436244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
    van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
    Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fancb deficiency impairs hematopoietic stem cell function.
    Du W; Amarachintha S; Erden O; Wilson A; Meetei AR; Andreassen PR; Namekawa SH; Pang Q
    Sci Rep; 2015 Dec; 5():18127. PubMed ID: 26658157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FANCB is essential in the male germline and regulates H3K9 methylation on the sex chromosomes during meiosis.
    Kato Y; Alavattam KG; Sin HS; Meetei AR; Pang Q; Andreassen PR; Namekawa SH
    Hum Mol Genet; 2015 Sep; 24(18):5234-49. PubMed ID: 26123487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction.
    Gross M; Hanenberg H; Lobitz S; Friedl R; Herterich S; Dietrich R; Gruhn B; Schindler D; Hoehn H
    Cytogenet Genome Res; 2002; 98(2-3):126-35. PubMed ID: 12697994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.